secwatch.observer — SEC 8-K summary
======================================

Issuer:     MYOMO, INC. (MYO)
CIK:        0001369290
Form:       8-K
Filed at:   2026-05-07T23:59:59+00:00
Accession:  0001193125-26-211928
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Myomo Q1 revenue $10.1M (+3% YoY); net loss narrows to $3.0M; guides Q2 $10.3M-$10.8M
--------------------------------------------------------------------------------

- Revenue $10.1M (+3% YoY), net loss $3.0M ($0.07/sh) vs $3.5M loss ($0.08/sh) in Q1 2025.
- Gross margin expanded to 68.2% (up 100 bps); operating expenses down 1% YoY to $10.1M.
- Orders received 239 (+12% YoY); backlog 226 (+14% vs Dec 2025); pipeline adds up 7% sequentially.
- Recurring patient source revenue reached 49% of total, up from 25% a year ago.
- Q2 2026 revenue guidance $10.3M-$10.8M; FY 2026 revenue reiterated at $43M-$46M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1369290/000119312526211928/0001193125-26-211928-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1369290/000119312526211928/myo-20260507.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-211928

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer